Stefania-Felicia Barbuceanu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Stefania-Felicia Barbuceanu has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
- George Mihai Nitulescu
Faculty of Pharmacy, “Carol Davila” University of Medicine and Pharmacy, Traian Vuia 6, 020956 Bucharest, Romania
11 shared publications - Octavian Tudorel Olaru
Faculty of Pharmacy, “Carol Davila” University of Medicine and Pharmacy, Traian Vuia 6, 020956 Bucharest, Romania
11 shared publications - Elena Pahonțu
General and Inorganic Chemistry Department Faculty of Pharmacy “Carol Davila” University of Medicine and Pharmacy Bucharest Romania
9 shared publications - Theodora-Venera Apostol
Organic Chemistry Department Faculty of Pharmacy “Carol Davila” University of Medicine and Pharmacy Bucharest Romania
9 shared publications - Laura Ileana Socea
Faculty of Pharmacy, “Carol Davila” University of Medicine and Pharmacy, 6 Traian Vuia Street, 020956 Bucharest, Romania
7 shared publications - Constantin Draghici
“C.D. Nenitescu” Institute of Organic and Supramolecular Chemistry, Romanian Academy, 202 B Splaiul Independentei, 060023 Bucharest, Romania
5 shared publications
Latest Publications
- Open Access
- 30 September 2026
- Published by Wiley in ChemistryOpen
- Vol. 15 (10) , e70315
2‐Chloro‐5‐(trifluoromethyl)aniline‐Derived Schiff Base Palladium(II) Complexes: From Molecular Design to Acute Toxicity Assessment
Four Schiff bases newly synthesized from 2‐chloro‐5‐(trifluoromethyl)aniline served as ligands for the preparation of four palladium(II) complexes. Characterization of all compounds was performed using the following physicochemical techniques: elemental analysis, IR, UV–vis, 1 H NMR, 13 C NMR, mass spectrometry, thermal analysis, molar conductivity, and magnetic susceptibility. In addition, crystals of the ligands HL 1 – HL 4 and the complexes 2 and 4 were obtained, enabling their structures to be confirmed by single‐crystal X‐ray diffraction. Crystallography showed that ligands form molecular crystals with one molecule per unit cell, except HL 1 , which contains two chemically identical molecules; HL 1 , HL 2 , and HL 4 are centrosymmetric, and HL 3 crystallizes as a pure enantiomer. Complex 4 is mononuclear, coordinated by two deprotonated ligands through an N 2 O 2 donor set, while complex 2 is dinuclear, with each palladium(II) coordinated via an O 3 N set by one bidentate anionic ligand and two bidentate‐bridging acetate anions. Phytotoxicity and animal toxicity were assessed using Triticum aestivum L. and Artemia franciscana Kellogg, respectively. Complexes were slightly more inhibitory than ligands on Triticum , but overall effects were weak, with root growth exceeding that of the negative control at all tested concentrations. Only complexes 2 and 4 exhibited dose‐dependent toxicity in Artemia , with LC 50 values of 389.8 and 48.7 µM.
- 30 September 2026
- Published by Wiley in ChemistryOpen
- Vol. 15 (10) , e70315
Open Access2‐Chloro‐5‐(trifluoromethyl)aniline‐Derived Schiff Base Palladium(II) Complexes: From Molecular Design to Acute Toxicity Assessment
Four Schiff bases newly synthesized from 2‐chloro‐5‐(trifluoromethyl)aniline served as ligands for the preparation of four palladium(II) complexes. Characterization of all compounds was performed using the following physicochemical techniques: elemental analysis, IR, UV–vis, 1 H NMR, 13 C NMR, mass spectrometry, thermal analysis, molar conductivity, and magnetic susceptibility. In addition, crystals of the ligands HL 1 – HL 4 and the complexes 2 and 4 were obtained, enabling their structures to be confirmed by single‐crystal X‐ray diffraction. Crystallography showed that ligands form molecular crystals with one molecule per unit cell, except HL 1 , which contains two chemically identical molecules; HL 1 , HL 2 , and HL 4 are centrosymmetric, and HL 3 crystallizes as a pure enantiomer. Complex 4 is mononuclear, coordinated by two deprotonated ligands through an N 2 O 2 donor set, while complex 2 is dinuclear, with each palladium(II) coordinated via an O 3 N set by one bidentate anionic ligand and two bidentate‐bridging acetate anions. Phytotoxicity and animal toxicity were assessed using Triticum aestivum L. and Artemia franciscana Kellogg, respectively. Complexes were slightly more inhibitory than ligands on Triticum , but overall effects were weak, with root growth exceeding that of the negative control at all tested concentrations. Only complexes 2 and 4 exhibited dose‐dependent toxicity in Artemia , with LC 50 values of 389.8 and 48.7 µM.
- Open Access
Synthesis, Characterization and Toxicity Evaluation of Some New Heterocyclic Compounds from Oxazole and 1,2,4-Triazine Classes
This study presents the synthesis of novel heterocyclic derivatives from oxazol-5(4H)-ones and 1,2,4-triazin-6(5H)-ones classes containing the 4-chlorophenylsulfonylphenyl and arylidene motifs as potential bioactive molecules. The synthesis of new oxazol-5(4H)-ones was conducted by cyclocondensation of 2-(4-(4-chlorophenylsulfonyl)benzamido)acetic acid with several aromatic aldehydes. The reaction of oxazol-5(4H)-ones with phenylhydrazine afforded the new 1,2,4-triazin-6(5H)-ones. Spectroscopic techniques (IR, 1H-, 13C-NMR, and MS) and elemental analysis were used to confirm the structures of all new compounds. The compounds were tested against Saccharomyces cerevisiae, and cells lacking the BLH1 gene were more susceptible to compound toxicity. Moreover, the compounds increased bleomycin toxicity against yeast cells. Structural similarity analysis against the ChEMBL database and approved drugs from DrugBank was performed to evaluate the structural novelty of the synthesized compounds and to obtain preliminary information regarding their potential pharmacological profiles.
Open AccessSynthesis, Characterization and Toxicity Evaluation of Some New Heterocyclic Compounds from Oxazole and 1,2,4-Triazine Classes
This study presents the synthesis of novel heterocyclic derivatives from oxazol-5(4H)-ones and 1,2,4-triazin-6(5H)-ones classes containing the 4-chlorophenylsulfonylphenyl and arylidene motifs as potential bioactive molecules. The synthesis of new oxazol-5(4H)-ones was conducted by cyclocondensation of 2-(4-(4-chlorophenylsulfonyl)benzamido)acetic acid with several aromatic aldehydes. The reaction of oxazol-5(4H)-ones with phenylhydrazine afforded the new 1,2,4-triazin-6(5H)-ones. Spectroscopic techniques (IR, 1H-, 13C-NMR, and MS) and elemental analysis were used to confirm the structures of all new compounds. The compounds were tested against Saccharomyces cerevisiae, and cells lacking the BLH1 gene were more susceptible to compound toxicity. Moreover, the compounds increased bleomycin toxicity against yeast cells. Structural similarity analysis against the ChEMBL database and approved drugs from DrugBank was performed to evaluate the structural novelty of the synthesized compounds and to obtain preliminary information regarding their potential pharmacological profiles.
- Open Access
- 7 January 2026
- Published by Wiley in ChemistrySelect
- Vol. 11 (1)
Pd(II) Complexes of Schiff Base Ligands Derived From 4‐Aminoantipyrine: Synthesis, Characterization, Crystal Structure and Acute Toxicity Evaluation
A series of palladium(II) complexes, [Pd(L 1 ) 2 ] ( 1 ), [Pd(L 2 ) 2 ]·2DMSO ( 2 ), [Pd(L 3 ) 2 ] ( 3 ), [Pd(L 4 )(CH 3 COO) 2 ] ( 4 ), [Pd(L 5 ) 2 ]·1.25H 2 O ( 5 ), and [Pd(L 6 ) 2 ] ( 6 ) with Schiff bases derived from 4‐aminoantipyrine, HL 1 – HL 6 , have been synthesized. The newly obtained ligands and corresponding complexes have been described using the following physicochemical methods: 1 H‐NMR, 13 C‐NMR, UV–vis, IR spectroscopies, elemental analysis, magnetic susceptibility, molar conductivity, and thermal analysis. Additionally, the molecular structures of ligands HL 1 , HL 3 , and HL 6 and complexes 1 , 2 , 3, and 6 were confirmed by single‐crystal X‐ray diffraction. All crystal structures were found to be centrosymmetric, with no interstitial solvent molecules, except for [Pd(L 2 ) 2 ]·2DMSO, which crystallized as a disolvate from DMSO. Furthermore, this analysis showed that each palladium(II) is coordinated by a set of four N 2 O 2 donor atoms, adopting a square‐planar geometry. The acute toxicity of all compounds was assessed on two species: the monocot Triticum aestivum L. and the aquatic crustacean Artemia franciscana Kellogg. The results from macroscopic and microscopic plant evaluations confirmed the absence of a phytotoxic effect for the ligands and indicated a weak effect for complexes 2 ‐ 6 . In addition, most of the tested compounds did not induce mortality in crustacean nauplii at concentrations up to 100 µM.
- 7 January 2026
- Published by Wiley in ChemistrySelect
- Vol. 11 (1)
Open AccessPd(II) Complexes of Schiff Base Ligands Derived From 4‐Aminoantipyrine: Synthesis, Characterization, Crystal Structure and Acute Toxicity Evaluation
A series of palladium(II) complexes, [Pd(L 1 ) 2 ] ( 1 ), [Pd(L 2 ) 2 ]·2DMSO ( 2 ), [Pd(L 3 ) 2 ] ( 3 ), [Pd(L 4 )(CH 3 COO) 2 ] ( 4 ), [Pd(L 5 ) 2 ]·1.25H 2 O ( 5 ), and [Pd(L 6 ) 2 ] ( 6 ) with Schiff bases derived from 4‐aminoantipyrine, HL 1 – HL 6 , have been synthesized. The newly obtained ligands and corresponding complexes have been described using the following physicochemical methods: 1 H‐NMR, 13 C‐NMR, UV–vis, IR spectroscopies, elemental analysis, magnetic susceptibility, molar conductivity, and thermal analysis. Additionally, the molecular structures of ligands HL 1 , HL 3 , and HL 6 and complexes 1 , 2 , 3, and 6 were confirmed by single‐crystal X‐ray diffraction. All crystal structures were found to be centrosymmetric, with no interstitial solvent molecules, except for [Pd(L 2 ) 2 ]·2DMSO, which crystallized as a disolvate from DMSO. Furthermore, this analysis showed that each palladium(II) is coordinated by a set of four N 2 O 2 donor atoms, adopting a square‐planar geometry. The acute toxicity of all compounds was assessed on two species: the monocot Triticum aestivum L. and the aquatic crustacean Artemia franciscana Kellogg. The results from macroscopic and microscopic plant evaluations confirmed the absence of a phytotoxic effect for the ligands and indicated a weak effect for complexes 2 ‐ 6 . In addition, most of the tested compounds did not induce mortality in crustacean nauplii at concentrations up to 100 µM.
- Open Access
Synthesis and Evaluation of Biologically Active Compounds from Heterocycles Class
Heterocyclic compounds represent one of the most important classes of natural and synthetic compounds, playing essential roles in various fields, including medicinal chemistry
Open AccessSynthesis and Evaluation of Biologically Active Compounds from Heterocycles Class
Heterocyclic compounds represent one of the most important classes of natural and synthetic compounds, playing essential roles in various fields, including medicinal chemistry
- Open Access
- 29 December 2023
- Published by MDPI AG in Pharmaceuticals
- Vol. 17 (1) , 62
Assessment of Some Unsymmetrical Porphyrins as Promising Molecules for Photodynamic Therapy of Cutaneous Disorders
In order to select for further development novel photosensitizers for photodynamic therapy in cutaneous disorders, three unsymmetrical porphyrins, namely 5-(4-hydroxy-3-methoxyphenyl)-10,15,20-tris-(4-acetoxy-3-methoxyphenyl) porphyrin (P2.2), 5-(2-hydroxy-5-methoxyphenyl)-10,15,20-tris-(4-carboxymethylphenyl) porphyrin (P3.2), and 5-(2,4-dihydroxyphenyl)-10,15,20-tris-(4-acetoxy-3-methoxyphenyl) porphyrin (P4.2), along with their fully symmetrical counterparts 5,10,15,20-tetrakis-(4-acetoxy-3-methoxyphenyl) porphyrin (P2.1) and 5,10,15,20-tetrakis-(4-carboxymethylphenyl) porphyrin (P3.1) were comparatively evaluated. The absorption and fluorescence properties, as well as atomic force microscopy measurements were performed to evaluate the photophysical characteristics as well as morphological and textural properties of the mentioned porphyrins. The cellular uptake of compounds and the effect of photodynamic therapy on the viability, proliferation, and necrosis of human HaCaT keratinocytes, human Hs27 skin fibroblasts, human skin SCL II squamous cell carcinoma, and B16F10 melanoma cells were assessed in vitro, in correlation with the structural and photophysical properties of the investigated porphyrins, and with the predictions regarding diffusion through cell membranes and ADMET properties. All samples were found to be isotropic and self-similar, with slightly different degrees of aggregability, had a relatively low predicted toxicity (class V), and a predicted long half-life after systemic administration. The in vitro study performed on non-malignant and malignant skin-relevant cells highlighted that the asymmetric P2.2 porphyrin qualified among the five investigated porphyrins to be a promising photosensitizer candidate for PDT in skin disorders. P2.2 was shown to accumulate well within cells, and induced by PDT a massive decrease in the number of metabolically active skin cells, partly due to cell death by necrosis. P2.2 had in this respect a better behavior than the symmetric P.2.1 compound and the related asymmetric compound P4.2. The strong action of P2.2-mediated PDT on normal skin cells might be an important drawback for further development of this compound. Meanwhile, the P3.1 and P3.2 compounds were not able to accumulate well in skin cells, and did not elicit significant PDT in vitro. Taken together, our experiments suggest that P2.2 can be a promising candidate for the development of novel photosensitizers for PDT in skin disorders.
- 29 December 2023
- Published by MDPI AG in Pharmaceuticals
- Vol. 17 (1) , 62
Open AccessAssessment of Some Unsymmetrical Porphyrins as Promising Molecules for Photodynamic Therapy of Cutaneous Disorders
In order to select for further development novel photosensitizers for photodynamic therapy in cutaneous disorders, three unsymmetrical porphyrins, namely 5-(4-hydroxy-3-methoxyphenyl)-10,15,20-tris-(4-acetoxy-3-methoxyphenyl) porphyrin (P2.2), 5-(2-hydroxy-5-methoxyphenyl)-10,15,20-tris-(4-carboxymethylphenyl) porphyrin (P3.2), and 5-(2,4-dihydroxyphenyl)-10,15,20-tris-(4-acetoxy-3-methoxyphenyl) porphyrin (P4.2), along with their fully symmetrical counterparts 5,10,15,20-tetrakis-(4-acetoxy-3-methoxyphenyl) porphyrin (P2.1) and 5,10,15,20-tetrakis-(4-carboxymethylphenyl) porphyrin (P3.1) were comparatively evaluated. The absorption and fluorescence properties, as well as atomic force microscopy measurements were performed to evaluate the photophysical characteristics as well as morphological and textural properties of the mentioned porphyrins. The cellular uptake of compounds and the effect of photodynamic therapy on the viability, proliferation, and necrosis of human HaCaT keratinocytes, human Hs27 skin fibroblasts, human skin SCL II squamous cell carcinoma, and B16F10 melanoma cells were assessed in vitro, in correlation with the structural and photophysical properties of the investigated porphyrins, and with the predictions regarding diffusion through cell membranes and ADMET properties. All samples were found to be isotropic and self-similar, with slightly different degrees of aggregability, had a relatively low predicted toxicity (class V), and a predicted long half-life after systemic administration. The in vitro study performed on non-malignant and malignant skin-relevant cells highlighted that the asymmetric P2.2 porphyrin qualified among the five investigated porphyrins to be a promising photosensitizer candidate for PDT in skin disorders. P2.2 was shown to accumulate well within cells, and induced by PDT a massive decrease in the number of metabolically active skin cells, partly due to cell death by necrosis. P2.2 had in this respect a better behavior than the symmetric P.2.1 compound and the related asymmetric compound P4.2. The strong action of P2.2-mediated PDT on normal skin cells might be an important drawback for further development of this compound. Meanwhile, the P3.1 and P3.2 compounds were not able to accumulate well in skin cells, and did not elicit significant PDT in vitro. Taken together, our experiments suggest that P2.2 can be a promising candidate for the development of novel photosensitizers for PDT in skin disorders.
- Open Access
- 19 July 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (14) , 11642
Synthesis, Characterization and Cytotoxic Evaluation of New Pyrrolo[1,2-b]pyridazines Obtained via Mesoionic Oxazolo-Pyridazinones
New pyrrolo[1,2-b]pyridazines were synthesized by 3 + 2 cycloaddition reaction between mesoionic oxazolo-pyridazinones and methyl/ethyl propiolate. The mesoionic compounds were generated in situ by action of acetic anhydride on 3(2H)pyridazinone acids obtained from corresponding esters by alkaline hydrolysis followed by acidification. The structures of the compounds were confirmed by elemental analyses and IR, 1H-NMR, 13C-NMR, and X-ray diffraction data. The regioselectivity of cycloaddition was evidenced by NMR spectroscopy and confirmed by X-ray analysis. The compounds were evaluated for their cytotoxicity on plant cells (Triticum aestivum L.) and crustacean animal cells (Artemia franciscana Kellogg and Daphnia magna Straus). The results indicated that the tested compounds exhibited low toxicity on the plant cell (IC50 values higher than 200 µM), while on Artemia nauplii no lethality was observed. Daphnia magna assay showed that pyrrolo[1,2-b]pyridazines 5a and 5c could exhibit toxic effects, whereas, for the other compounds, toxicity was low to moderate. Also, the cytotoxic effects of the compounds were tested on three human adenocarcinoma-derived adherent cell lines (colon LoVo, ovary SK-OV-3, breast MCF-7). The in vitro compound-mediated cytotoxicity assays, performed by the MTS technique, demonstrated dose- and time-dependent cytotoxic activity for several compounds, the highest anti-tumor activity being observed for 5a, 2c, and 5f, especially against colon cancer cells.
- 19 July 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (14) , 11642
Open AccessSynthesis, Characterization and Cytotoxic Evaluation of New Pyrrolo[1,2-b]pyridazines Obtained via Mesoionic Oxazolo-Pyridazinones
New pyrrolo[1,2-b]pyridazines were synthesized by 3 + 2 cycloaddition reaction between mesoionic oxazolo-pyridazinones and methyl/ethyl propiolate. The mesoionic compounds were generated in situ by action of acetic anhydride on 3(2H)pyridazinone acids obtained from corresponding esters by alkaline hydrolysis followed by acidification. The structures of the compounds were confirmed by elemental analyses and IR, 1H-NMR, 13C-NMR, and X-ray diffraction data. The regioselectivity of cycloaddition was evidenced by NMR spectroscopy and confirmed by X-ray analysis. The compounds were evaluated for their cytotoxicity on plant cells (Triticum aestivum L.) and crustacean animal cells (Artemia franciscana Kellogg and Daphnia magna Straus). The results indicated that the tested compounds exhibited low toxicity on the plant cell (IC50 values higher than 200 µM), while on Artemia nauplii no lethality was observed. Daphnia magna assay showed that pyrrolo[1,2-b]pyridazines 5a and 5c could exhibit toxic effects, whereas, for the other compounds, toxicity was low to moderate. Also, the cytotoxic effects of the compounds were tested on three human adenocarcinoma-derived adherent cell lines (colon LoVo, ovary SK-OV-3, breast MCF-7). The in vitro compound-mediated cytotoxicity assays, performed by the MTS technique, demonstrated dose- and time-dependent cytotoxic activity for several compounds, the highest anti-tumor activity being observed for 5a, 2c, and 5f, especially against colon cancer cells.
- Top Cited PapersOpen Access
The Importance of the Pyrazole Scaffold in the Design of Protein Kinases Inhibitors as Targeted Anticancer Therapies
The altered activation or overexpression of protein kinases (PKs) is a major subject of research in oncology and their inhibition using small molecules, protein kinases inhibitors (PKI) is the best available option for the cure of cancer. The pyrazole ring is extensively employed in the field of medicinal chemistry and drug development strategies, playing a vital role as a fundamental framework in the structure of various PKIs. This scaffold holds major importance and is considered a privileged structure based on its synthetic accessibility, drug-like properties, and its versatile bioisosteric replacement function. It has proven to play a key role in many PKI, such as the inhibitors of Akt, Aurora kinases, MAPK, B-raf, JAK, Bcr-Abl, c-Met, PDGFR, FGFRT, and RET. Of the 74 small molecule PKI approved by the US FDA, 8 contain a pyrazole ring: Avapritinib, Asciminib, Crizotinib, Encorafenib, Erdafitinib, Pralsetinib, Pirtobrutinib, and Ruxolitinib. The focus of this review is on the importance of the unfused pyrazole ring within the clinically tested PKI and on the additional required elements of their chemical structures. Related important pyrazole fused scaffolds like indazole, pyrrolo[1,2-b]pyrazole, pyrazolo[4,3-b]pyridine, pyrazolo[1,5-a]pyrimidine, or pyrazolo[3,4-d]pyrimidine are beyond the subject of this work.
Top Cited PapersOpen AccessThe Importance of the Pyrazole Scaffold in the Design of Protein Kinases Inhibitors as Targeted Anticancer Therapies
The altered activation or overexpression of protein kinases (PKs) is a major subject of research in oncology and their inhibition using small molecules, protein kinases inhibitors (PKI) is the best available option for the cure of cancer. The pyrazole ring is extensively employed in the field of medicinal chemistry and drug development strategies, playing a vital role as a fundamental framework in the structure of various PKIs. This scaffold holds major importance and is considered a privileged structure based on its synthetic accessibility, drug-like properties, and its versatile bioisosteric replacement function. It has proven to play a key role in many PKI, such as the inhibitors of Akt, Aurora kinases, MAPK, B-raf, JAK, Bcr-Abl, c-Met, PDGFR, FGFRT, and RET. Of the 74 small molecule PKI approved by the US FDA, 8 contain a pyrazole ring: Avapritinib, Asciminib, Crizotinib, Encorafenib, Erdafitinib, Pralsetinib, Pirtobrutinib, and Ruxolitinib. The focus of this review is on the importance of the unfused pyrazole ring within the clinically tested PKI and on the additional required elements of their chemical structures. Related important pyrazole fused scaffolds like indazole, pyrrolo[1,2-b]pyrazole, pyrazolo[4,3-b]pyridine, pyrazolo[1,5-a]pyrimidine, or pyrazolo[3,4-d]pyrimidine are beyond the subject of this work.
- Open Access
New Heterocyclic Compounds from Oxazol-5(4H)-one and 1,2,4-Triazin-6(5H)-one Classes: Synthesis, Characterization and Toxicity Evaluation
This paper describes the synthesis of new heterocycles from oxazol-5(4H)-one and 1,2,4-triazin-6(5H)-one classes containing a phenyl-/4-bromophenylsulfonylphenyl moiety. The oxazol-5(4H)-ones were obtained via condensation of 2-(4-(4-X-phenylsulfonyl)benzamido)acetic acids with benzaldehyde/4-fluorobenzaldehyde in acetic anhydride and in the presence of sodium acetate. The reaction of oxazolones with phenylhydrazine, in acetic acid and sodium acetate, yielded the corresponding 1,2,4-triazin-6(5H)-ones. The structures of the compounds were confirmed using spectral (FT-IR, 1H-NMR, 13C-NMR, MS) and elemental analysis. The toxicity of the compounds was evaluated on Daphnia magna Straus crustaceans and on the budding yeast Saccharomyces cerevisiae. The results indicate that both the heterocyclic nucleus and halogen atoms significantly influenced the toxicity against D. magna, with the oxazolones being less toxic than triazinones. The halogen-free oxazolone had the lowest toxicity, and the fluorine-containing triazinone exhibited the highest toxicity. The compounds showed low toxicity against yeast cells, apparently due to the activity of plasma membrane multidrug transporters Pdr5 and Snq2. The predictive analyses indicated an antiproliferative effect as the most probable biological action. The PASS prediction and CHEMBL similarity studies show evidence that the compounds could inhibit certain relevant oncological protein kinases. These results correlated with toxicity assays suggest that halogen-free oxazolone could be a good candidate for future anticancer investigations.
Open AccessNew Heterocyclic Compounds from Oxazol-5(4H)-one and 1,2,4-Triazin-6(5H)-one Classes: Synthesis, Characterization and Toxicity Evaluation
This paper describes the synthesis of new heterocycles from oxazol-5(4H)-one and 1,2,4-triazin-6(5H)-one classes containing a phenyl-/4-bromophenylsulfonylphenyl moiety. The oxazol-5(4H)-ones were obtained via condensation of 2-(4-(4-X-phenylsulfonyl)benzamido)acetic acids with benzaldehyde/4-fluorobenzaldehyde in acetic anhydride and in the presence of sodium acetate. The reaction of oxazolones with phenylhydrazine, in acetic acid and sodium acetate, yielded the corresponding 1,2,4-triazin-6(5H)-ones. The structures of the compounds were confirmed using spectral (FT-IR, 1H-NMR, 13C-NMR, MS) and elemental analysis. The toxicity of the compounds was evaluated on Daphnia magna Straus crustaceans and on the budding yeast Saccharomyces cerevisiae. The results indicate that both the heterocyclic nucleus and halogen atoms significantly influenced the toxicity against D. magna, with the oxazolones being less toxic than triazinones. The halogen-free oxazolone had the lowest toxicity, and the fluorine-containing triazinone exhibited the highest toxicity. The compounds showed low toxicity against yeast cells, apparently due to the activity of plasma membrane multidrug transporters Pdr5 and Snq2. The predictive analyses indicated an antiproliferative effect as the most probable biological action. The PASS prediction and CHEMBL similarity studies show evidence that the compounds could inhibit certain relevant oncological protein kinases. These results correlated with toxicity assays suggest that halogen-free oxazolone could be a good candidate for future anticancer investigations.
- Open Access
Acylhydrazones and Their Biological Activity: A Review
Due to the structure of acylhydrazones both by the pharmacophore –CO–NH–N= group and by the different substituents present in the molecules of compounds of this class, various pharmacological activities were reported, including antitumor, antimicrobial, antiviral, antiparasitic, anti-inflammatory, immunomodulatory, antiedematous, antiglaucomatous, antidiabetic, antioxidant, and actions on the central nervous system and on the cardiovascular system. This fragment is found in the structure of several drugs used in the therapy of some diseases that are at the top of public health problems, like microbial infections and cardiovascular diseases. Moreover, the acylhydrazone moiety is present in the structure of some compounds with possible applications in the treatment of other different pathologies, such as schizophrenia, Parkinson’s disease, Alzheimer’s disease, and Huntington’s disease. Considering these aspects, we consider that a study of the literature data regarding the structural and biological properties of these compounds is useful.
Open AccessAcylhydrazones and Their Biological Activity: A Review
Due to the structure of acylhydrazones both by the pharmacophore –CO–NH–N= group and by the different substituents present in the molecules of compounds of this class, various pharmacological activities were reported, including antitumor, antimicrobial, antiviral, antiparasitic, anti-inflammatory, immunomodulatory, antiedematous, antiglaucomatous, antidiabetic, antioxidant, and actions on the central nervous system and on the cardiovascular system. This fragment is found in the structure of several drugs used in the therapy of some diseases that are at the top of public health problems, like microbial infections and cardiovascular diseases. Moreover, the acylhydrazone moiety is present in the structure of some compounds with possible applications in the treatment of other different pathologies, such as schizophrenia, Parkinson’s disease, Alzheimer’s disease, and Huntington’s disease. Considering these aspects, we consider that a study of the literature data regarding the structural and biological properties of these compounds is useful.
- Open Access
Synthesis, Characterization, and Biological Evaluation of Novel N-{4-[(4-Bromophenyl)sulfonyl]benzoyl}-L-valine Derivatives
In this article, we present the design and synthesis of novel compounds, containing in their molecules an L-valine residue and a 4-[(4-bromophenyl)sulfonyl]phenyl moiety, which belong to N-acyl-α-amino acids, 4H-1,3-oxazol-5-ones, 2-acylamino ketones, and 1,3-oxazoles chemotypes. The synthesized compounds were characterized through elemental analysis, MS, NMR, UV/VIS, and FTIR spectroscopic techniques, the data obtained being in accordance with the assigned structures. Their purities were verified by reversed-phase HPLC. The new compounds were tested for antimicrobial action against bacterial and fungal strains, for antioxidant activity by DPPH, ABTS, and ferric reducing power assays, and for toxicity on freshwater cladoceran Daphnia magna Straus. Furthermore, in silico studies were performed concerning the potential antimicrobial effect and toxicity. The results of antimicrobial activity, antioxidant effect, and toxicity assays, as well as of in silico analysis revealed a promising potential of N-{4-[(4-bromophenyl)sulfonyl]benzoyl}-L-valine and 2-{4-[(4-bromophenyl)sulfonyl]phenyl}-4-isopropyl-4H-1,3-oxazol-5-one for developing novel antimicrobial agents to fight Gram-positive pathogens, and particularly Enterococcus faecium biofilm-associated infections.
Open AccessSynthesis, Characterization, and Biological Evaluation of Novel N-{4-[(4-Bromophenyl)sulfonyl]benzoyl}-L-valine Derivatives
In this article, we present the design and synthesis of novel compounds, containing in their molecules an L-valine residue and a 4-[(4-bromophenyl)sulfonyl]phenyl moiety, which belong to N-acyl-α-amino acids, 4H-1,3-oxazol-5-ones, 2-acylamino ketones, and 1,3-oxazoles chemotypes. The synthesized compounds were characterized through elemental analysis, MS, NMR, UV/VIS, and FTIR spectroscopic techniques, the data obtained being in accordance with the assigned structures. Their purities were verified by reversed-phase HPLC. The new compounds were tested for antimicrobial action against bacterial and fungal strains, for antioxidant activity by DPPH, ABTS, and ferric reducing power assays, and for toxicity on freshwater cladoceran Daphnia magna Straus. Furthermore, in silico studies were performed concerning the potential antimicrobial effect and toxicity. The results of antimicrobial activity, antioxidant effect, and toxicity assays, as well as of in silico analysis revealed a promising potential of N-{4-[(4-bromophenyl)sulfonyl]benzoyl}-L-valine and 2-{4-[(4-bromophenyl)sulfonyl]phenyl}-4-isopropyl-4H-1,3-oxazol-5-one for developing novel antimicrobial agents to fight Gram-positive pathogens, and particularly Enterococcus faecium biofilm-associated infections.